Innovative Solutions for Nucleic Acid based Therapeutics

Specializing in discovery and preclinical program guideline development for Nucleic Acid-based Tx.

Zachary Kennedy: Lead Consultant

Experience in Nucleic Acid Therapeutics, siRNAs, and oligonucleotides. Focused on developing novel treatments for diseases with significant unmet needs. PhD with 10+ years of laboratory experience with multiple nucleic acid therapeutic modalities that include chemically modified oligonucleotides, Gene Therapy and CRISPR gene editing. Experience with designing discovery pipelines, and RNA design for small RNAs and Gene Therapy payloads. Experience with high throughput screening and lead candidate evaluation and preclinical development. Record of working in cross-functional Industry teams.

RNA Therapeutics

Expertise in RNA therapeutic target validation, Discovery, Screening, and lead candidate refinement

Gene Therapy

Experience in AAV capsid payload design for increased expression and improving immunosafety profile

Program Management

Expertise in managing program and acheiving timeles. Manage in-house researc and CRO reserarch for discovery and preclinical stage programs